Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Ocular Therapeutix Inc’s current trading price is -4.07% away from its 52-week high, while its distance from the 52-week low is 442.86%. The stock’s price range during this period has varied between $2.00 and $11.29. The company, active in the Healthcare sector, saw a trading volume of around 3.0 million for the day, considerably higher average daily volume of 1.92 million observed over the last three months.
In terms of market performance, Ocular Therapeutix Inc had a somewhat regular. The highest value for the stock in the past year was $11.29 on 03/06/24, while the lowest value was $2.00 on 11/10/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Ocular Therapeutix Inc (OCUL) has experienced a quarterly rise of 222.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.19B and boasts a workforce of 274 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.43, with a change in price of +8.05. Similarly, Ocular Therapeutix Inc recorded 1,596,101 in trading volume during the last 100 days, posting a change of +289.57%.
How OCUL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for OCUL stands at 10.58. Similarly, the long-term debt-to-equity ratio is also 10.34.
OCUL Stock Stochastic Average
As of today, the raw stochastic average of Ocular Therapeutix Inc over the last 50 days is at 93.64%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 92.44%. Further, the company’s Stochastic %K and %D values for the last 20 days were 93.54% and 94.33%, respectively.
OCUL Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 142.83%. However, over the last six months, the performance has been weaker by 176.28%. The price of OCUL increased 118.79% over the last 30 days. And in the last five days, it has surged by 8.84%.
